Presentation is loading. Please wait.

Presentation is loading. Please wait.

The New EP23 Laboratory Quality Control Based on Risk Management, Approved Guideline Luann Ochs, MS Senior Vice President – Operations Clinical and Laboratory.

Similar presentations

Presentation on theme: "The New EP23 Laboratory Quality Control Based on Risk Management, Approved Guideline Luann Ochs, MS Senior Vice President – Operations Clinical and Laboratory."— Presentation transcript:

1 The New EP23 Laboratory Quality Control Based on Risk Management, Approved Guideline Luann Ochs, MS Senior Vice President – Operations Clinical and Laboratory Standards Institute

2 Objectives Describe the various types of control processes. Identify CLSI document EP23-A as a resource for developing a laboratory quality control (QC) plan based on risk management. Review key aspects of risk management. 2

3 3 Todays Quality Control Advantages –QC monitors the end product (result) of the entire test system. –QC has target values: if assay recovers target, then everything is assumed stable (instrument, reagent, operator, sample). Disadvantages –When a problem is detected, one must go back and reanalyze patients since last good QC. –If results are released, then results may need to be corrected. –For Point of Care devices, does traditional QC work for every test? Need to get to fully automated analyzers that eliminate errors up front –Until that time, need a robust QC plan (QCP)

4 4 Types of Quality Control On-Board or Analyzer QC – built-in device controls or system checks Internal QC – laboratory-analyzed surrogate sample controls External QC – blind proficiency survey Other types of QC – control processes either engineered by a manufacturer or enacted by a laboratory to ensure result reliability

5 5

6 6 Quality Control Limitations No single QC procedure can cover all devices, because the devices may differ. QC practices developed over the years have provided laboratories with some degree of assurance that results are valid. Newer devices have built-in electronic controls, and on-board chemical and biological controls. QC information from the manufacturer increases the users understanding of devices overall quality assurance requirements.

7 The Quality Control Toolbox Every QC tool has its strengths and weaknesses (there is no perfect QC tool). Implement a combination of tools in order to properly control a test. EP23 explains the strengths and weaknesses of the different QC processes, and helps the laboratory determine the right combination of tools: The Right QC 7

8 CLSI Document EP23 Laboratory Quality Control Based on Risk Management; Approved Guideline James H. Nichols, PhD, DABCC, FACB, Chairholder of the document development committee EP23 describes good laboratory practice for developing a QCP based on the manufacturers risk mitigation information, applicable regulatory and accreditation requirements, and the individual health care and laboratory setting. 8

9 The Scenario CLSI document EP23 provides guidance on developing an appropriate QCP that will: –Save time and money. –Use electronic and/or integrated QC features. –Use other sources of QC information. –Conform to ones laboratory and clinical use of the test. 9

10 Developing a QCP 10 MEASURING SYSTEM INFORMATION Medical Requirements for the Test Results Regulatory and Accreditation Requirements Test System Information - Provided by the Manufacturer - Obtained by the Laboratory Information About Health Care and Test Site Setting PROCESS Risk Assessment OUTPUT Quality Control Plan PROCESS Post-implementation Monitoring

11 Measuring System Information Gather information from several sources: –Medical requirements for the test results Allowable performance specifications via physicians –Regulatory and accreditation requirements Clinical Laboratory Improvement Amendments –Test/test system information Users manual, reagent package insert, literature Prior laboratory data –Health care and testing site settings Temperature conditions, operator training programs 11

12 Developing a Process Map Break down all phases of the test/test system into steps, so that weak points can be identified. Each step can be analyzed to find potential failure modes that could present significant risk to patients. Process can then be further analyzed to see if controls can be put into place to avoid the failures. 12

13 Process Map 13

14 Developing a Process Map (contd) Compile this information. A process map or a fishbone diagram is one example. 14

15 The Risk Assessment Once the process map is created, examine it for places where errors could occur. Five major areas: –Samples –Operator –Reagents –Laboratory environment –Measuring system 15

16 Key Process Steps Think about what steps can be taken to reduce errors unrelated to the actual testing of the sample. 16 PREPARATION Pre-analytical Pre-examination TESTING Analytical Examination RESULT REPORTING Post-analytical Post-examination

17 Perform the Risk Assessment Identify the potential failures and their causes. –Review the process map, fishbone diagram, manufacturers instructions, etc. Assess each potential failure. Where a failure could occur, add an element to the QCP that will reduce the possibility of that failure, making residual risk acceptable. –For some types of failures, the manufacturers information may already have a quality check in place. 17

18 Perform the Risk Assessment Risk Assessment and Risk Management are formal terms for what youre already doing. 18

19 19 Risk Definition Risk – the chance of suffering or encountering harm or loss (Webster's Dictionary and Thesaurus. Ashland, OH: Landall, Inc.; 1993). Risk, can be estimated through a combination of the probability of occurrence of harm and the severity of that harm (ISO/IEC Guide 51). Risk, essentially is the potential for an error to occur that could lead to patient/staff harm.

20 Life is a Continual Risk Assessment 20 You assess risk every day, all the time, usually without even thinking about it.

21 In the Laboratory 21 You do this every day!

22 Assess the Risk of Harm Due to Failures 22 Defective IVD: Hazard Incorrect or delayed test result: Hazard Incorrect or delayed medical treatment: Hazardous Situation Injury or death: Harm

23 Perform the Risk Assessment (contd) Construct a table; see which types of errors are detected and which ones are not. –If not detected, it must be included in the QCP. For each possible failure, assess the likelihood of that failure occurring, and the severity of consequences if it occurs. –Do this for each identified failure. –Use all of the information gathered in order to make these assessments. 23

24 Risk Assessment Worksheet 24

25 Frequency (1 – 5) Example (Sometimes called Probability) 25 Common Terms RatingExample (ISO 14971) Practical Example Frequent5 1/1,000More than 1x/week Probable4< 1/1,000 and 1/10,000 Once every few months Occasional3< 1/10,000 and 1/100,000 Once a year Remote2< 1/100,000 and 1/1,000,000 Once every few years Improbable1< 1/1,000,000 and 10,000,000 Unlikely to ever happen The laboratory must decide – and it may be different for different tests!

26 Severity (1 – 5) Example 26 Common Terms RatingPossible Description (ISO 14971) Catastrophic5Results in patient death Critical4Results in permanent injury of life- threatening injury Serious3Results in injury or impairment requiring professional medical intervention Minor2Results in temporary injury or impairment not requiring professional medical intervention Negligible1Inconvenience or temporary discomfort

27 Detectability (1 – 5) What is the likelihood that the control process detects or prevents the failure? 27 Common Terms RatingExample Low5Control is ineffective 4Control less likely to detect the failure 3Control may or may not detect the failure 2Control almost always detects the failure High1Control can detect the failure

28 Risk Acceptability Matrix 28

29 Criticality Multiply Frequency x Severity x Detectability Example: Probable (4) x Catastrophic (5) x High likelihood to detect failure (1) = CriticalityResult Low<10 Mid10 – 20 High>20 Higher criticality numbers must have quality control actions in place.

30 Assemble the Quality Control Plan Use the information gathered earlier to assess all of the identified risks and their control measures. Construct the QCP. Include each of the identified QCP actions in the QCP. 30

31 Monitor QCP for Effectiveness Verify that the QCP that is put in place actually works Continue to monitor errors and control failures. If an error occurs: –Take the appropriate corrective action. –Investigate the cause of the error. –Once the cause is understood, evaluate whether any changes need to be made in the QCP. 31

32 Monitor QCP for Effectiveness (contd) Review any complaints that the laboratory receives from health care providers. –These complaints may include pointing out another source of QC failure that must be addressed. For patient safety, the QCP should be reviewed and monitored on an ongoing basis to ensure that the QCP is optimal. 32

33 Summary A QCP is necessary for result quality, and each QCP is unique. A QCP is the industry standard. It depends upon the extent to which the devices features achieve their intended purpose in union with the laboratorys expectation for ensuring quality results. Once implemented, the QCP is monitored for effectiveness and modified as needed to maintain risk at a clinically acceptable level. 33

34 EP23 Companion Products 34 Risk Assessment Worksheet Implementation Workbook Plus – More fully worked examples coming soon

Download ppt "The New EP23 Laboratory Quality Control Based on Risk Management, Approved Guideline Luann Ochs, MS Senior Vice President – Operations Clinical and Laboratory."

Similar presentations

Ads by Google